Dextromethorphan hydrobromide and dextromethorphan polistirex (extended release formulation) is an over the counter drug indicated for use as a cough suppressant that temporarily relieves cough due to minor throat and bronchial irritation that often occurs due to common cold. Dextromethorphan shows high affinity binding to several regions of the brain, including the medullary cough center and is the d-isomer of the codeine analog of levorphanol. This compound is an NMDA receptor antagonist and acts as a non-competitive channel blocker. It is one of the most widely used antitussives and is also used to study the involvement of glutamate receptors in neurotoxicity. It is a synthetic morphine derivative that, in contrast to its levorotatory isomer, has no significant analgesic, respiratory depressant or physical dependency properties at recommended doses.
Affygility Solutions has an occupational exposure limit (OEL) and control band assignment for this active pharmaceutical ingredient (API). This monograph also contains the acceptable daily exposure (ADE) value.
OEL Fastrac monographs are a cost-effective and convenient way to meet the requirements for PDEs (ADEs) contained in the EMA Guideline on setting health based exposure limits for use in risk identification in the manufacture of different medicinal products in shared facilities (EMA/CHMP/CVMP/SWP/169430/2012), and to obtain the following information:
To order an OEL monograph for this compound, just click the ADD TO CART button.
Not the compound you were looking for? You can search the OEL Fastrac catalog to find more available compounds.
Affygility Solutions’s OEL Fastrac service is an user-friendly system that enables us to make confident decisions and focus on moving the compound safely through our facility. We can quickly access the database to determine if a new drug is within the OEL Fastrac library, and if so, immediately download a detailed OEL banding report. The OEL Fastrac system has been a helpful tool in our overall EH&S program.